WO1989004967A1 - Procede et appareil d'analyse chimique - Google Patents
Procede et appareil d'analyse chimique Download PDFInfo
- Publication number
- WO1989004967A1 WO1989004967A1 PCT/DK1988/000191 DK8800191W WO8904967A1 WO 1989004967 A1 WO1989004967 A1 WO 1989004967A1 DK 8800191 W DK8800191 W DK 8800191W WO 8904967 A1 WO8904967 A1 WO 8904967A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analyte
- fluid
- concentration
- sample
- urea
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 239000000126 substance Substances 0.000 title claims abstract description 13
- 238000004458 analytical method Methods 0.000 title abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 46
- 238000012360 testing method Methods 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 239000004202 carbamide Substances 0.000 claims description 85
- 238000004401 flow injection analysis Methods 0.000 claims description 84
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 84
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 63
- 239000008280 blood Substances 0.000 claims description 63
- 239000008103 glucose Substances 0.000 claims description 63
- 210000004369 blood Anatomy 0.000 claims description 62
- 239000012491 analyte Substances 0.000 claims description 38
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 37
- 239000006185 dispersion Substances 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 28
- 108010046334 Urease Proteins 0.000 claims description 26
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 229910021529 ammonia Inorganic materials 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 14
- 238000009792 diffusion process Methods 0.000 claims description 13
- 230000004044 response Effects 0.000 claims description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 9
- 230000002452 interceptive effect Effects 0.000 claims description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 8
- 229960005489 paracetamol Drugs 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 230000003750 conditioning effect Effects 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 239000013626 chemical specie Substances 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000006174 pH buffer Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 description 74
- 239000012528 membrane Substances 0.000 description 63
- 229940088598 enzyme Drugs 0.000 description 49
- 108090000790 Enzymes Proteins 0.000 description 48
- 102000004190 Enzymes Human genes 0.000 description 48
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 27
- 238000005259 measurement Methods 0.000 description 27
- 238000002347 injection Methods 0.000 description 24
- 239000007924 injection Substances 0.000 description 24
- 238000001514 detection method Methods 0.000 description 23
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 22
- 229910052700 potassium Inorganic materials 0.000 description 22
- 239000011591 potassium Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 238000005534 hematocrit Methods 0.000 description 19
- 210000002381 plasma Anatomy 0.000 description 18
- 239000007789 gas Substances 0.000 description 17
- 230000008859 change Effects 0.000 description 15
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 238000003556 assay Methods 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 12
- 239000012488 sample solution Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 230000003139 buffering effect Effects 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 108010015776 Glucose oxidase Proteins 0.000 description 9
- 239000004366 Glucose oxidase Substances 0.000 description 9
- 229940116332 glucose oxidase Drugs 0.000 description 9
- 235000019420 glucose oxidase Nutrition 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 8
- 239000002696 acid base indicator Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000013307 optical fiber Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- RMIXHJPMNBXMBU-UHFFFAOYSA-N Nonactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 RMIXHJPMNBXMBU-UHFFFAOYSA-N 0.000 description 5
- -1 ammonium ions Chemical class 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000007515 enzymatic degradation Effects 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 239000012482 calibration solution Substances 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 3
- YPUPRVWRYDPGCW-UHFFFAOYSA-N Monactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 YPUPRVWRYDPGCW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 229940116871 l-lactate Drugs 0.000 description 3
- YPUPRVWRYDPGCW-GGOMOPATSA-N monactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](C)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](C)OC(=O)[C@H]1C)CC)C(=O)O[C@H](C)C[C@H]2CC[C@@H]1O2 YPUPRVWRYDPGCW-GGOMOPATSA-N 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 239000013026 undiluted sample Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 2
- 241000220451 Canavalia Species 0.000 description 2
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- RMIXHJPMNBXMBU-QIIXEHPYSA-N Nonactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](C)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](C)OC(=O)[C@H]1C)C)C(=O)O[C@H](C)C[C@H]2CC[C@@H]1O2 RMIXHJPMNBXMBU-QIIXEHPYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- YTCQFLFGFXZUSN-BAQGIRSFSA-N microline Chemical compound OC12OC3(C)COC2(O)C(C(/Cl)=C/C)=CC(=O)C21C3C2 YTCQFLFGFXZUSN-BAQGIRSFSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100036808 Carboxylesterase 3 Human genes 0.000 description 1
- 229920013683 Celanese Polymers 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101000851624 Homo sapiens Carboxylesterase 3 Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 208000009451 Hyperglycemic Hyperosmolar Nonketotic Coma Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000008083 Urea Assay Methods 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000027734 detection of oxygen Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001546 nitrifying effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000001507 sample dispersion Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
Definitions
- the methods according to the invention has the features of claim 1 or claim 2 or claim 3.
- the preferred embodiments have the features of claims 4-9.
- the analyte sensor may be an electrochemical sensor, an optical sensor or any other suitable sensor means.
- the fluid element is stationary and is held by any suitable support means, such as a porous or fibrous member in the shape of a film, a sheet, a block, a cylinder or any other suitable shape, e.g. a ceramic pin or a thread, a hydrophilic or porous membrane, a gelled structure etc..
- a suitable support means such as a porous or fibrous member in the shape of a film, a sheet, a block, a cylinder or any other suitable shape, e.g. a ceramic pin or a thread, a hydrophilic or porous membrane, a gelled structure etc.
- the chemical composition of the fluid element may be maintained by conditioning the fluid element with the carrier fluid prior to the contact with each individual sample.
- the fluid element is preferably an aqueous composition.
- the analyzer according to the present invention has the features of claim 10 and the preferred embodiments have the features of claims 11-13.
- the analyzer according to the invention is an analyzer with a sample inlet, a sample conduit, a sensor means arranged proximate to a test location of the sample conduit and a sample outlet and further with support means for the fluid element arranged between the actual fluid sample under test and the sensor means.
- the sample may be fed to the analyzer in any conventional manner, e.g. by injection or aspiration.
- the sample is transported through the analyzer by $ means of a flowing carrier fluid.
- the carrier fluid may constitute the conditioning medium of controlled chemical composition.
- There may be direct contact between the sample and the carrier fluid or there may be a plug of an immiscible fluid such as a plug of oil or of gas separating sample and carrier fluid.
- the analyzer may be of the conventional flow injection analyzer type.
- the analyzer will be able to handle in series more than 30 samples per hour.
- Fig. 1(b) shows an exploded view of a gas diffusion/detection unit shown in Fig. 1(a).
- Fig. 2 shows a calibration graph for urea?
- Fig. 3 shows a FIA manifold for the detection of wea using an ion-selective electrode
- Fig. 4 shows a FIA manifold for the detection of glucose or lactate
- a miniaturized flow injection system for the assay of urea in undiluted whole blood is described. Based on the optical determination of o ammonia, the system incorporates a flow cell combining gas diffusion and optosensing, the separating barrier betweeen the donor and accepting streams consisting of a sandwich of a hydrophilic membrane between which is contained a s gel of covalently immobilized urease.
- the sample urea content is quantified by the colour change of an acid-base indicator contained within the acceptor stream. Within the physiological range the measurement is not affected by variations in 0 the pH value, the buffering capacity or the
- Urea is the final product of human protein metabolism. Determination of blood urea makes it posible to trace and follow changes in protein ° and amino acid composition, and the concentration of urea in blood is an important index of renal, function. In clinical chemistry blood urea is traditionally asayed in the serum or plasma fraction, yet the ultimate goal is to perform the measurement in the original sample matrix since this requires a minimum of manipulations, and hence a shorter time to obtain the analytical result, such an apparoach furthermore facilitates the possibility of continuous monitoring. Besides, the importance to confine manual handling of blood samples has been emphasised in recent years due to increased occurrence of contagious diseases.
- Urea is frequently determined by the indophenol colorimetric method (5), yet most of the work reported in the literature has been devoted to development and use of enzyme electrodes.
- the nonactin/monactin electrode (2) provides poor o selectivity for ammonium ions over potassium, but the interference can be compensated for by introducing a second ammonium selective electrode for NH- and K background detection (4).
- Sensing of the pH changes generated in a 5 urease-gel, wrapped around a pH electrode, is another approach (6-8). This type of ammonia sensor yields excellent selectivity for ammonia over ions in the solution (9), yet besides being pH sensitive its response is rather slow.
- a o hybride urea sensor consisting of an immobilized layer of nitrifying bacteria with ultimate detection of oxygen with an oxygen electrode has been reported (10).
- An ammonia sensitive In/Pd MOS capacitor (11-13) has been suggested as an s alternative to the ammonia gas electrode with the added advantage of being inexpensive.
- the gas diffusion/detection unit (Fig. lb) was constructed of black PVC.
- the unit comprises two separate parts (A and B) between which, when assembled by four screws, the membrane sandwich is contained.
- part A Into part A is milled a 1 x 1 x 20 mm groove communicating with two perpendicularly drilled holes (0,5 mm ID) serving as in- (I) and outlets (0) for the acceptor stream.
- part B embodies a 1 x 1 x 10 mm groove served by in- and outlets for the donor stream.
- the membrane sandwich consists of a gas permeable membrane (G) ⁇ Celgard 2500, hydrophobic polypropylene polymer, thickness 25 ⁇ m, pore size 0.004 ⁇ i , Celanese, Belgium), and an enzyme membrane (M) (see below).
- G gas permeable membrane
- M enzyme membrane
- the optical measurement of the colour of the acid-base indicator is effected by reflectance, the nontransparent white gas permeable membrane serving as a reflecting opaque background, which, in order to further improve the reflected signal, is supplemented by the incorporaration of a thin foil of gold (GF) placed opposite the optical fibre.
- GF thin foil of gold
- the signal from the optical fibre photometer was sent to a recorder (Radiometer Servograph REC 61, furnished with a REA-112 high-sensitivity interface), the peak height at peak maximum serving as the analytical readout.
- aqueous urea standards in the range 1-35.0 mM used for calibrating the system were prepared by o appropriate dilutions with 0.01 M phosphate buffer of pH 7.2 of a 35.0 mM stock solution made by dissolving 2.102 g of urea (Riedel-de Haen) in 1 1 of 0.01 M phosphate buffer of pH 7.2.
- Immobilized Enzyme Membranes 40 mg of urease from "jack beans” (E.C. 3.5.1.5, Sigma, 70 U/mg) and 30 mg of bovine serum o albumine were completely dissolved in 0.3 ml of phosphate buffer (10 mM, pH 7.2) and 20 11 of glutaraldehyde (25% aqueous solution) was added.
- a controlled dispersion of the sample zone while it is passing through the system towards the s detector is essential in Flow Injection
- the sensing process in fact, occurs in two steps: In the first step, where the injected sample is in contact with the enzyme layer, the degradation of urea to ammonium takes place.
- the first step where the injected sample is in contact with the enzyme layer, the degradation of urea to ammonium takes place.
- the amount of ammonia ultimately diffusing into the acceptor stream of the system in Fig. 1 is of such magnitude that 5 the ensuing absorbance change registered by the optical system is sufficient to obtain a reliable signal.
- additional signal enhancement may be o obtained by operating the donor stream and especially the acceptor stream in a stopped-flow mode (14) .
- Assay of Standards, Plasma and Whole Blood Samples For actual urea assays the FIA manifold depicted in Fig. la was used. A typical calibration graph obtained with a series of aqueous urea standards is shown in Fig. 2.
- the dynamic measuring range is 0-35 mM urea with a linear range from 0 to 6 mM urea (the normal physiological range).
- the curvature of the calibration plot might be due to several factors. In order to obtain a linear relationship between the urea concentration and the recorded absorbance signal the following two conditions must be fulfilled:
- the activity of the membrane sandwich remained constant during at least one week of continuous daily operation, upon which some deterioration in the measured signal appeared.
- Urea in whole blood, enzymatically degraded by immobilized urease followed by colorimetric detection of the ammonia generated can be 5 determined in a FIA system provided that the dispersion coefficient of the injected sample at the point of quantification is as close to unity as possible. With this condition fulfilled, the analytical readout is independent of any ° variations in the pH, the buffering capacity and the hematocrit level of individual samples.
- ABSTRACT 5 A flow injection system for the assay of urea in undiluted whole blood is described. Quantification of urea is achieved by means of an ammonium ion-selective electrode furnished with a membrane incorporating immobilized urease o measuring the enzymatically generated ammonium which is directly related to the concentration of the urea. The interference from potassium is reduced by adjusting the potassium concentration in the carrier stream and in the aqueous s calibration solutions to 4.0 mM. However, a complete elimination of this interference is achieved by measuring the actual potassium concentration in the respective sample using an external instrument, thus mathematically 0 correcting for the additional contribution to the signal due to the presence of K .
- the linear measuring range is 1-40 mM urea with a sample frequency of 40 h ⁇ and a standard deviation of 1% for whole blood samples.
- the result of the 5 measurement is obtained within 25 sec. from the time of injection. Variations in the hematocrit level of the sample has no effect on the measurement.
- the method is in excellent agreement with the one used routinely at a local 0 County Hospital.
- the sensor is stable for more than 30 days.
- Enzyme sensors or electrodes as they are conventionably called, consists of an electrode covered with a membrane layer containing one or possibly more enzymes. This type of electrodes have proved to be useful in biochemical analysis and have been developed for a variety of substrates. The enzyme catalyses the reaction of the substrate to be measured by generating or o consuming species for which the inner sensor is selective. In most cases, covalently immobilized rather than physically entrapped enzymes are preferred, because covalent immobilization techniques generally offers increased stability 5 of the enzyme activity. Enzyme electrodes have the advantage of being simple, reliable, essentially reagentless and sensitive, besides being highly selective due to the inherent selectivety of the enzymes.
- nonactin/monactin electrode used provides poor selectivity for.ammonium ions over potassium.
- An urea electrode of similar composition was used by Yasuda et.al. (2) in conjunction with a FIA system, where the interference from potassium was compensated for by using an additional ammonium ion-selective electrode (without enzyme) for K detection. This system proved to be s linear in the range 3.6-107 mM urea. However, attempts to determine urea in whole blood was impeded due to influence by the hematocrit level of the sample.
- the FIA manifold therefore should, for pratical assays, 5 be operated at a D-value as close as possible to 1, that is, the distance between the injection port and the detection position should be minimized (3, 4).
- E standard electrode potential 0 (temperature dependent)
- R is the gas constant
- T is the absolute temperature (K)
- F is the Faraday constant
- ax is the ion activity - ⁇ .
- y J x denotes the activity - ⁇ coefficient which is governed by the total ionic strength, I, of the sample.
- the ionic strength is defined as:
- c. concentration of each ionic species present in the sample and z. is the charge of each ionic species present in the sample.
- the activity coefficient can, up to an ionic
- a and B are general constants assuming a value of 0.5115 and 0.3291 respectively at 25 C and a is the specific ion size parameter.
- Kxi. values When.Kxi. values are known, it is p e ossible to compensate for interferences by making appropriate calculations. However, it must be remembered that the K value is not a constant. It varies to some degree with the concentration level of the primary ion (analyte) and of the interfering species, sample composition, time and temperature.
- K 1. from electrode to electrode was evaluated with and without the incorporation of an enzyme membrane using 5 different electrodes (ASE.-ASAg).
- the K. value was only determined in the range 1-10 M urea and 1-10 mM ammonium. At higher concentration levels the interference from potasiu is of less importance. As expected, the "naked" ASE can be made very reproducible (cf. Table 2) owing to the uniformity of the PVC ion-selective membranes. TABLE 2 Determination of K. as a function of the
- Kx indicates the K value at an urea concentration of x mM
- a typical calibration graph is obtained with a series of aqueous urea standards. At urea 5 concentrations higher than 40 mM the calibration graph is no longer lineari The curvature of the calibration plot at concentrations above 40 M urea might be due to several factors.
- the following three conditions must be fulfilled: (a) The kinetics of the urease enzyme has to follow that of pseudo-first order reaction conditions, i.e. the amount of urease must be in excess and CureaD « K-, s (Michaelis-Menten constant).
- the coefficient of variation for 10 measurements l o of a blood sample was 1.06%.
- the correlation coefficient is 0.999. up to - 15% can occur. Even though the actual determinations of the potassium have been made in a static system, there is no reason, whatsoever, that a FIA system similar to that used for the derermination of urea, should not be used in conjunction with a potassium ion-selective electrode, thus making a parallel determination of these two analytes.
- a computer controlled flow ' injection system for the assay of D-glucose and L-lactic acid in undiluted plasma is described. Quantification of glucose/lactate is achieved by coupling of an immobilized glucose oxidase/lactate oxidase enzyme membrane with an amperometric electrode, thus measuring the enzymatically generated hydrogen peroxide, which is directly related to the concentration of glucose/lactate.
- the amperometric electrodee consists of a platinum anode, to which a potential of +600 mV is applied, and a Ag/AgCl cathode. The diameter of the exposed electrode surface is 2.5 mm. The linear range is 0-40 mM and 0-10 mM for glucose and lactic acid respectively.
- the sample ffrreeqquueennccyy i iss 66C0 h with a standard deviation of less than 1.5%.
- Analysis of blood glucose are used to detect hyper- and hypo-glycaemia, both of which can result from a variety of different disorders, many of them of endocrine origin.
- hyperglycaemia is diabetes mellitus, and elderly patients may present in hyperosmolar non-ketotic coma with blood glucose levels as high as 60 mmol/L.
- serial blood glucose levels are required to monitor diabetes on treatment, and to detect and ultimately to prevent gestational hyperglycaemia which although not necessarily harmful to the mother, may be damaging to the foetus (1) .
- the arterial lactate concentration is now recognized as a very good indicator of severity and prognosis (2, 3).
- the increases in blood lactate are due to a critical reduction in oxygen delivery such that aerobic metabolism through the Krebs cycle cannot be sustained.
- the severity of the defect in oxygen delivery is proportional to the increase in lactate generated through the emergency pathway of glucose metabolism from pyruvate.
- Samples (25 ⁇ l ) were injected into the single line FIA system depicted in Fig. 4 by means of a 5 rotary valve operated by a step motor.
- the distance between,the injection port and the 10 JJ.1 flow cell (FC) was made as short as possible in order to ensure minimum dispersion of the sample zone.
- a special designed electrode comprising a central 0.4 mm diameter platinum working electrode with an outer 2.5 mm-diameter silver ring as the reference electrode was polarized at + 600 mV and used for hydrogen peroxide detection.
- the electrode system was connected to a home-built potentiostat and the current intensity as a function of time was recorded by a BBC computer from Acorn DFS utilizing the built-in analogue to digital facility.
- the carrier stream 0 was propelled by means of a Radiometer A/S ABU80 syringe pump (PI) at 1.0 ml/min.
- PI Radiometer A/S ABU80 syringe pump
- the BBC computer facilitated the data aquisition and the operation of the sampling pump, the syringe pump and the injection valve.
- the isotonic phosphate buffer used as carrier stream was prepared by dissolving 1.12 g of NaEDTA, 1.84 g NaBenzoate, 3.04 g NaH 2 P0 4 , 13.80 g Na 2 HP0 4 and 5.44 g NaCl in 2 1 of distilled water.
- Aqueous glucose and lactate standards were prepared from stock solutions containing 100 mM glucose and 100 mM lactate respectively.
- high rejective glucose or high rejective lactate membranes (3.0 mm diameter) purchased from Yellow Springs Instrument Co. was placed on the electrode tip and fixed with an outer polycarbonate membrane (Nucleopore, 5 ⁇ m thick, 0.08 urn pore size) held with an o-ring.
- control of the sampling and syringe pump 5) presentation of data i.e. the concentration in mM, the time of peak maximum and the sample no.
- Eqn. (11) is not valid for enzyme systems which require additional cosubstrate(s) or coenzyme(s). Nevertheless eqn. (11) has proved 5 to be a very useful approximation as long as the cosubstrate(s) or coenzyme(s) are in excess. In order to obtain a linear relationship between the glucose or the lactate concentration and the recorded signal the two following conditions must be fulfilled:
- a typical calibration run is obtained with a series of aqueous glucose standards. It is worth while to notice that the result of the analysis is completed within 5 sec. from the time of injection.
- the linear range is 0-40 mM glucose with a sample frequency of 60 h " and a standard deviation of less than 1.5%.
- a potential of 600-650 mV is chosen because the current is not affected by small changes of the potential in this range.
- a potential of +300 V can be used in conjunction with a three electrode system.
- the high rejective glucose oxidase membrane was then replaced with a high rejection lactate oxidase membrane, and a series of 11 blood plasma samples, supplied by the Copenhagen County 5 Hospital in Herlev (CCHH), were assayed in order to compare the FIA method with the YSI lactate analyzer.
- a FIA system has been applied for detection of glucose and lactate in plasma using an amperometric electrode with detection of enzymatically generated hydrogen peroxide.
- the analysis is completed within 5 sec. and there is no interference from other species.
- the linear range is 0-40 mM glucose and 0-10 mM lactate with aa ssaammppllee ffrreeqquueennccyy ooff 6600 hh ⁇ and a standard deviation of less than 1.5%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK6225/87 | 1987-11-27 | ||
DK622587A DK622587D0 (da) | 1987-11-27 | 1987-11-27 | Fremgangsmaade og apparat til kemisk analyse |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1989004967A1 true WO1989004967A1 (fr) | 1989-06-01 |
Family
ID=8148155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1988/000191 WO1989004967A1 (fr) | 1987-11-27 | 1988-11-24 | Procede et appareil d'analyse chimique |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0389545A1 (fr) |
DK (1) | DK622587D0 (fr) |
WO (1) | WO1989004967A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0670491A2 (fr) * | 1994-03-02 | 1995-09-06 | Centro De Estudios E Investigacion Del Agua | Procédé et dispositif pour mesurer la concentration d'ammonium total dans un milieu liquide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0120202A2 (fr) * | 1983-01-21 | 1984-10-03 | Hitachi, Ltd. | Senseur électrochimique capable de déterminer la concentration en péroxyde d'hydrogène et analyseur équipé de ce senseur |
-
1987
- 1987-11-27 DK DK622587A patent/DK622587D0/da not_active Application Discontinuation
-
1988
- 1988-11-24 EP EP19890900194 patent/EP0389545A1/fr not_active Ceased
- 1988-11-24 WO PCT/DK1988/000191 patent/WO1989004967A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0120202A2 (fr) * | 1983-01-21 | 1984-10-03 | Hitachi, Ltd. | Senseur électrochimique capable de déterminer la concentration en péroxyde d'hydrogène et analyseur équipé de ce senseur |
Non-Patent Citations (5)
Title |
---|
Analyst, Vol. 109, January 1984, K. YASUDA et al: "Determination of Urea in Whole Blood using a Urea Electrode with an Immobilised Urease Membrane", pages 61-64, see the whole document * |
Analytical Chemistry, Vol. 58, No. 6, May 1986, B. OLSSON et al: "Theory and Application of Diffusion - Limited Amperometric Enzyme Electrod Detection in Flow Injection Analysis of Glucose", pages 1046-1052, see especially results and discussion. * |
CHEMICAL ABSTRACTS, Vol. 106, No. 5, 2 February 1987, F. SCHELLER et al: "Flow Injection analysis of Lactate and Lactatedehydrogenas using an Enzym Membrane in Conjunction with a Modified Electrode", Abstract Number 29536X & Anal. Lett., 1986, Vol. 19 (15-16), pages 1691-703, Abstract. * |
Dialog Informational Services, File 305, Analytical Abstracts, Acces. No. 47-08-D-00105, F. WINQVIST et al: "Determination of Urea with an Ammonia-Gas-Sensitive Semiconductor Device in Combination with Urease" & Anal. Chem. Acta, Vol. 163, pages 143-149, September 1984, Abstract. * |
Dialog Informational Services, File 305, Analytical Abstracts, Acces. No. 50-08-D-00172, B. PETERSSON et al: "Determination of Urea in Undiluted Blood Samples by Flow Injection Analysis using Optosensing" & Anal. Lett., Vol. 20 (12), December 1987, pages 1977-1994, Abstract * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0670491A2 (fr) * | 1994-03-02 | 1995-09-06 | Centro De Estudios E Investigacion Del Agua | Procédé et dispositif pour mesurer la concentration d'ammonium total dans un milieu liquide |
EP0670491A3 (fr) * | 1994-03-02 | 1996-05-15 | Estudios E Invest Del Agua | Procédé et dispositif pour mesurer la concentration d'ammonium total dans un milieu liquide. |
Also Published As
Publication number | Publication date |
---|---|
EP0389545A1 (fr) | 1990-10-03 |
DK622587D0 (da) | 1987-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vadgama | Enzyme electrodes as practical biosensors | |
AU754095B2 (en) | Microfabricated aperture-based sensor | |
US4890620A (en) | Two-dimensional diffusion glucose substrate sensing electrode | |
Lowe | Biosensors | |
Azevedo et al. | Ethanol biosensors based on alcohol oxidase | |
D'Orazio | Biosensors in clinical chemistry | |
Scheller et al. | Biosensors: trends and commercialization | |
USRE41264E1 (en) | Biosensor with peroxidase enzyme | |
Han et al. | A methylene blue-mediated enzyme electrode for the determination of trace mercury (II), mercury (I), methylmercury, and mercury–glutathione complex | |
Lowe | Biosensors | |
Tvorynska et al. | Flow amperometric uric acid biosensors based on different enzymatic mini-reactors: A comparative study of uricase immobilization | |
Mascini et al. | Clinical uses of enzyme electrode probes | |
Guilbault | [41] Enzyme electrodes and solid surface fluorescence methods | |
Mor et al. | Assay of glucose using an electrochemical enzymatic sensor | |
US4547280A (en) | Maltose sensor | |
Kucherenko et al. | Novel multiplexed biosensor system for the determination of lactate and pyruvate in blood serum | |
Petersson | Amperometric assay of glucose and lactic acid by flow injection analysis | |
Wilson et al. | Unmediated amperometric enzyme electrodes | |
Petersson et al. | Determination of urea in undiluted blood samples by flow injection analysis using optosensin | |
CA1247700A (fr) | Electrode de detection du glucose a diffusion bidimensionnelle | |
WO1989004967A1 (fr) | Procede et appareil d'analyse chimique | |
Keyes et al. | Glucose analysis utilizing immobilized enzymes | |
US5741709A (en) | Multiple injection analysis | |
Clark Jr et al. | Rapid electroenzymatic measurement of lactate in microsamples of spinal fluid | |
Monroe | Amperometric immunoassay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1989900194 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): DK JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWP | Wipo information: published in national office |
Ref document number: 1989900194 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1989900194 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989900194 Country of ref document: EP |